2 ne ne TE Sp
2
tr
“|
Summary of Thyroid Reaults
& You
ah,
=
Py
Table 25
Age at
Exposure
Rongelap
In Utero
<10
10-18
>18
All Ages
Total
Number
3
15
3
3
23
l
0
It
4
Sifo
<10
10-18
-
All Agee
19
Utirik
In Utero
<10 .
10-18
>18
All Agee
All Exposed
In Utero
<10
10-18
>18
All Ages
8
No. with
Carcinoma
2
ige
12
3
65
“InUterc
218
Nodules®
0
\
]
2
4
0
0.079
0.50
0.92
2.7
4.2
0.026
Expected
Cancers>s¢
0.026
0.17
0.15
0.21
0.56
0.0087
640
4000
1700
1300
2100
610
Mean
Nodule Time
at Risk
(Cancer),
years
23(-)
13(15)
17(22)
17(13)
15(16)
-(-)
Mean Nodule
Risk, No.
per 10
person-radyeara
43
15
6.0
0.44
9.2
2
-
0
-
0.18
-
0.061
-
1100
-
22¢-).
-(-)
il
6
0
1.2
0.15
670
19{-)
20
0
0
0
167
17
12
82
31
126
251
2
21
7
16
46
56
19
64
Expected
Nodules>s©
Mean
Adsorbed
Dose,
rads
4
4
9
i
2
1
0.98
0.21
0.075
0.070
410
130
18(-)
-(-)
47
-
Mean Cancer
Risk, No.
per 10
person-radyeare
-
0.73
1.9
3.4
1.6.
-
-
-
-
-
-
4
1.5
1.4
7.5
11
0.49
0.24
0.58
490
220
170
25(21)
22(22)
22(22)
3.6
2?
4.8
0.89
19.
1.3
0
2
3
3
6
0.32
2.2
2.3
Il
16
0.10
0.72
0.39
0.87
2.1
290
1400
790
470
600
23(-)
16(18)
20(22)
20(16)
18(19)
21
10
9.6
4.4
8.3
0.65
3.1
2.2
1.5
®Iincludes some cases not surgically treated.
bBased on prevalence in unexposed Marshallese.
“In utero values based on age less than ten prevalence.
Smultiply by 100 to obtain number per 106 per son-gray-yeara.
®Does not include two boys with thyroid atrophy.
1.4
280
23(22)
5.9
(2.5